Phase 2 Parkinson's Disease Trial, Not Yet Recruiting NCT07471230 Sponsor: Biocells Medical Condition: Parkinson's Disease
Back to Parkinsons Disease

Phase 2 Parkinson's Disease Trial, Not Yet Recruiting

NCT07471230
Not Yet Recruiting Phase 2

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People between 40 and 80 years of age
  • People who have been diagnosed with Parkinsonism by a doctor
  • People whose Parkinsonism is at a moderate stage, meaning some movement difficulties but still able to walk without assistance (confirm with trial site)
  • People whose Parkinsonism medication has remained the same for at least 3 months

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People whose movement disorder has been identified as an atypical parkinsonian condition not related to neurodegeneration (confirm with trial site)
  • People who have had a cancer diagnosis within the last 5 years
  • People with serious heart or blood vessel disease
  • People who have previously received a cellular therapy treatment
  • People who currently have an active infection or are taking medication that suppresses the immune system

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026

Contact this trial

Phone: +48452365311

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Phase 2
Sponsor
Biocells Medical
Registry
ClinicalTrials.gov
Start date
23 November 2026
Est. completion
23 November 2028

Where this trial is recruiting

🇵🇱 Poland

Primary endpoints

NMSS

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov